Outsourcing Outlook

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2002
Volume 26
Issue 9

The author discusses the potential effect on CROs of pending major-pharma mergers and consolidations.

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology